Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
American Journal of Respiratory and Critical Care Medicine|December 27, 2011
Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized studyMoira L Aitken, Gabriel Bellon, Kris De Boeck, et al.Resuscitation|January 31, 2026
ECPR eligible refractory out of hospital cardiac arrests - a post-hoc analysis of the EVIDENCE Randomised Controlled Trial and RegistryMiles Greenberg, Brian Burns, Patrick Lay, et al.JBMR Plus|April 3, 2025
Phenotypic characterization of ENPP1 deficiency: generalized arterial calcification of infancy and autosomal recessive hypophosphatemic rickets type 2Carlos R Ferreira, Mary E Hackbarth, Yvonne Nitschke, et al.BMJ Open|October 21, 2025
Randomised controlled trial to assess the efficiency and effectiveness of remote care compared with in-clinic care for adult cochlear implant recipients in the first 12 months after activation: a protocol of the INSPIRE studyNicola Quaranta, Alessandra Murri, Sam Denys, et al.Circulation|March 13, 2002
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?R John Simes, Ian C Marschner, David Hunt, et al.European Journal of Endocrinology|July 5, 2023
Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trialKristy P Robledo, Ian C Marschner, David J Handelsman, et al.Respirology (Carlton, Vic.)|October 7, 2025
Inhaled Ciclesonide for Community-Based COVID-19: A Placebo-Controlled Randomised TrialPeter Wark, Ian C Marschner, Owen Hutchings, et al.American Heart Journal|June 24, 2010
Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trialR John Simes, Rachel L O'Connell, Philip E Aylward, et al.Journal of the American Heart Association|October 25, 2013
Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease studyHarvey D White, John Simes, Ralph A H Stewart, et al.European Journal of Endocrinology|December 25, 2024
Predicting type 2 diabetes and testosterone effects in high-risk Australian men: development and external validation of a 2-year risk modelKristy P Robledo, Ian C Marschner, Mathis Grossmann, et al.Pageof 6